Truist Financial Boosts agilon health (NYSE:AGL) Price Target to $6.50
agilon health (NYSE:AGL – Free Report) had its price objective lifted by Truist Financial from $6.40 to $6.50 in a research report released on Friday, Benzinga reports. The firm currently has a hold rating on the stock. Several other research firms also recently commented on AGL. Benchmark dropped their target price on agilon health from […]
More Stories
FY2025 EPS Estimates for Extendicare Increased by Analyst
Extendicare Inc. (TSE:EXE – Free Report) – Equities researchers at Leede Financial upped their FY2025 earnings per share estimates for...
FY2025 EPS Estimates for Extendicare Increased by Analyst
Extendicare Inc. (TSE:EXE – Free Report) – Equities researchers at Leede Financial upped their FY2025 earnings per share estimates for...
FY2025 EPS Estimates for Extendicare Increased by Analyst
Extendicare Inc. (TSE:EXE – Free Report) – Equities researchers at Leede Financial upped their FY2025 earnings per share estimates for...
FY2026 EPS Estimates for Precigen Decreased by HC Wainwright
Precigen, Inc. (NASDAQ:PGEN – Free Report) – Research analysts at HC Wainwright reduced their FY2026 earnings per share estimates for...
FY2026 EPS Estimates for Precigen Decreased by HC Wainwright
Precigen, Inc. (NASDAQ:PGEN – Free Report) – Research analysts at HC Wainwright reduced their FY2026 earnings per share estimates for...
FY2026 EPS Estimates for Precigen Decreased by HC Wainwright
Precigen, Inc. (NASDAQ:PGEN – Free Report) – Research analysts at HC Wainwright reduced their FY2026 earnings per share estimates for...